Home › Chronic-Phase Myeloid Leukemia
Chronic-Phase Myeloid Leukemia clinical trials recruiting in the U.S.
11 studies for Chronic-Phase Myeloid Leukemia are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX5 studies
- New York City, NY3 studies
- Birmingham, AL3 studies
- Seattle, WA3 studies
- Portland, OR3 studies
By state
- Alabama3 studies
- California5 studies
- Georgia3 studies
- New York5 studies
- North Carolina3 studies
- Oregon4 studies
- Texas6 studies
- Washington3 studies
Recently updated studies
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT04838041Personalized NK Cell Therapy in CBT
RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Jul 30, 2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07020533A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Jul 20, 2026 · NCT07091019Registry of Older Patients With Cancer
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Recruiting
Ages 0 to 25 · All sexes · Updated May 13, 2026 · NCT05794880A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT05304377Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT06229860A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jan 12, 2026 · NCT06163430From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.